Posted October 05, 2009 in Blog, Botox and Facial Fillers, Uncategorized
Allergan has filed a federal lawsuit seeking a court ruling that would allow it to share relevant information with the medical community on the safe use of botulinum toxin A for certain off-label therapeutic uses, the company announced in a press release.
In the suit, “Allergan contends that the government’s legal position that it is a crime for a pharmaceutical company to proactively communicate truthful information to physicians about off-label uses of its products violates the First Amendment and is inconsistent with the Federal Food, Drug & Cosmetic Act,” the release said. “The lawsuit does not involve Botox Cosmetic.”
The suit does not challenge the government’s ability to prohibit pharmaceutical companies from distributing false or misleading information about products.
“Rather, the lawsuit only seeks to permit Allergan to proactively provide the medical community with truthful, important information about common off-label uses of Botox,” the release said. “Moreover, far from seeking freedom from regulation, Allergan hopes this suit will lead to clear regulatory guidance on how it can lawfully provide accurate and relevant information on the full range of issues physicians should consider in determining the best therapies for their patients.”
Dr Persky is located in Encino, California but services all of Los Angeles and the San Fernando Valley. Including, Beverly Hills, Hollywood, Santa Monica, Malibu, Sherman Oaks, Studio City, Calabasas, Woodland Hills, Tarzana and Agoura Hills and more.
